NCT01179659View on ClinicalTrials.gov

Bioequivalence Study of Pantoprazole 40 mg DR Tablets and Protonix 40 mg Tablets Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

November 30, 2005

Study Completion Date

March 31, 2006

Conditions
Healthy
Interventions
DRUG

Pantoprazole 40 mg DR Tablet vs. Protonix 40 mg DR Tablet

Single dose crossover BE study

Trial Locations (1)

H4R 2N6

MDS Pharma Services, Saint-Laurent, Montreal

Sponsors
All Listed Sponsors
lead

Kremers Urban Development Company

INDUSTRY

NCT01179659 - Bioequivalence Study of Pantoprazole 40 mg DR Tablets and Protonix 40 mg Tablets Under Fed Conditions | Biotech Hunter | Biotech Hunter